3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pain, Postoperative
5
Leiomyoma
4
Breast Neoplasms
4
Agnosia
4
Pancreatic Neoplasms
3
Lung Neoplasms
2
Breast Cancer Female
2
Vesico-Ureteral Reflux
1
Ureteral Neoplasms
1
Thyroid Neoplasms
1
Neuroma
1
Nephrolithiasis
1
Lymphedema
1
Liver Neoplasms
1
Laparoscopic Surgery
1
Kidney Neoplasms
1
Ileus
1
Hyperthyroidism
1
Gynecologic Surgical Procedures
1
Goiter
1
Duodenal Neoplasms
1
Disease
1
Digestive System Diseases
1
Chronic Pain
1
Cerebrovascular Disorders
1
Adenomyosis
1
Interventions
pembrolizumab
59
Cisplatin
45
Cetuximab
29
Radiotherapy
26
Carboplatin
24
Docetaxel
17
Paclitaxel
16
Nivolumab
16
Surveys and Questionnaires
15
Radiotherapy, Intensity-Modulated
13
Fluorouracil
12
Drug Therapy
12
Blood Specimen Collection
11
Standard of Care
8
tislelizumab
7
cemiplimab
6
atezolizumab
6
Radiation
6
Chemoradiotherapy
6
toripalimab
5
Cyclophosphamide
5
130-nm albumin-bound paclitaxel
5
nimotuzumab
4
fludarabine
4
durvalumab
4
dostarlimab
4
Surgical Procedures, Operative
4
Afatinib
4
palbociclib
3
niraparib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Bupivacaine
×
1 year
×
Clear all
No trials found.